The potential danger of journal summary services

Timo Freeth


On 29 April, NEJM Journal Watch published a summary of a recent trial of single-dose dexamethasone for acute asthma compared with the current standard of 5-day prednisone. Unfortunately the one-line opening paragraph of the summary (which was the only line in the email alert) stated the opposite of the actual outcome of the trial. It is conceivable that practitioners around the world might change their practice on the basis of this one-line summary, with grave consequences.

Author's affiliations

Timo Freeth, Cape Town, South Africa

Full Text

PDF (42KB)


Jurnal summary services; NEJM Journal Watch; Single-dose dexamethasone

Cite this article

South African Medical Journal 2016;106(9):842. DOI:10.7196/SAMJ.2016.v106i9.11088

Article History

Date submitted: 2016-05-26
Date published: 2016-08-08

Article Views

Abstract views: 1970
Full text views: 609

Comments on this article

*Read our policy for posting comments here